Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19
NCT ID: NCT04435353
Last Updated: 2020-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2020-03-22
2021-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effectiveness of Vibroacoustic Therapy in the Complex Treatment of Acute Respiratory Failure
NCT03911947
Comparison of Two Respiratory Physiotherapy Treatments in Postcovid-19 Patients.
NCT05435443
Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)
NCT04344431
NHF vs. COT in Hypoxemic Pandemic Viral Illness
NCT04750408
Outcome Comparisons of Vibratory Airway Clearance Devices
NCT05873504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Time-day of respiratory fail
Objective data
VibroLUNG
Lungs intensive therapy
Oxygen status
Facultative data
VibroLUNG
Lungs intensive therapy
Oxugen support
FiO2
VibroLUNG
Lungs intensive therapy
Adverse outcomes
Complication
VibroLUNG
Lungs intensive therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VibroLUNG
Lungs intensive therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. P/F less 300 torr
3. ARDS by Berlin convention
4. COVID 19 bilateral pneumonia
Exclusion Criteria
2. acute brain stroke
3. acute coronary syndrome
4. pulmonary embolism
5. implanted pacemaker
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astana Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mukatova Irina
PhD. Professor of medicine. Head of deparment pulmonology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mukatova Irina
Astana, Astana, Kazakhstan
Center of pulmonology Astana
Astana, , Kazakhstan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ivan Vahrushev, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AstanaMU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.